Boundless Bio, Inc.
BOLD · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $1,086 | $0 | $0 | $0 |
| Gross Profit | -$1,086 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $55,267 | $42,637 | $37,159 | $19,278 |
| G&A Expenses | $18,000 | $12,159 | $9,310 | $6,023 |
| SG&A Expenses | $18,000 | $12,159 | $9,310 | $6,023 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$1,086 | $0 | $0 | $0 |
| Operating Expenses | $72,181 | $54,796 | $46,469 | $25,301 |
| Operating Income | -$73,267 | -$54,796 | -$46,469 | -$25,301 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $7,904 | $5,362 | $568 | $91 |
| Pre-Tax Income | -$65,363 | -$49,434 | -$45,901 | -$25,210 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$65,363 | -$49,434 | -$45,901 | -$25,210 |
| % Margin | – | – | – | – |
| EPS | -3.85 | -2.22 | -2.06 | -1.13 |
| % Growth | -73.4% | -7.8% | -82.3% | – |
| EPS Diluted | -3.85 | -2.22 | -2.06 | -1.13 |
| Weighted Avg Shares Out | 16,984 | 22,239 | 22,239 | 22,239 |
| Weighted Avg Shares Out Dil | 16,984 | 22,239 | 22,239 | 22,239 |
| Supplemental Information | – | – | – | – |
| Interest Income | $7,892 | $5,282 | $668 | $96 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1,086 | $957 | $942 | $682 |
| EBITDA | -$64,277 | -$53,839 | -$45,527 | -$24,619 |
| % Margin | – | – | – | – |